Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of British Columbia
$27,000.00
Investigating the effects of acute BRCA1 loss
FY 2025-26
Summary
Breast cancer is the leading cause of cancer related deaths in women under 50. Often these cancers are caused by hereditary variations in the breast cancer 1 gene, BRCA1, which can lead to aggressive and difficult to treat forms of cancer. The BRCA1 gene encodes a protein, called BRCA1, that has important roles in critical cellular functions: cell division and DNA damage repair. Disruption to these functions, brought on by variants in its gene, can promote the formation of tumors and cancer progression. The mechanisms and immediate reaction of cells to the loss of BRCA1 remains unknown.
In this project, I will study genetically modified breast epithelial cells which rapidly degrade their BRCA1 protein upon application of a drug. This allows me to precisely control the presence of BRCA1, and investigate the immediate and earliest impacts of BRCA1 loss, via the application of the drug.
By using live-cell microscopy, I will investigate different aspects of the initial cell divisions following the loss of BRCA1 and determine how acute loss of BRCA1 leads to extreme cell division abnormalities within cells. I will also study how cells initially respond to radiation induced DNA damage by exposing cells to radiation, following the application of the drug and determine how the immediate loss of BRCA1 impacts the different components of the cellular response to DNA damage. This research will uncover how cells react immediately following the loss of BRCA1 through aspects of cell division and response to DNA damage, and reveal previously uncharacterized early events in the disease progression of BRCA1 associated cancers.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
572729
Name
Gallant Aidan K
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the effects of acute BRCA1 loss
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Brca1; Breast Cancer; Cancer; Cell Division; Crispr; Dna Damage; Genes; Mammary Gland; Microtubules; Radiation
Abstract
Breast cancer is the leading cause of cancer related deaths in women under 50. Often these cancers are caused by hereditary variations in the breast cancer 1 gene, BRCA1, which can lead to aggressive and difficult to treat forms of cancer. The BRCA1 gene encodes a protein, called BRCA1, that has important roles in critical cellular functions: cell division and DNA damage repair. Disruption to these functions, brought on by variants in its gene, can promote the formation of tumors and cancer progression. The mechanisms and immediate reaction of cells to the loss of BRCA1 remains unknown.
In this project, I will study genetically modified breast epithelial cells which rapidly degrade their BRCA1 protein upon application of a drug. This allows me to precisely control the presence of BRCA1, and investigate the immediate and earliest impacts of BRCA1 loss, via the application of the drug.
By using live-cell microscopy, I will investigate different aspects of the initial cell divisions following the loss of BRCA1 and determine how acute loss of BRCA1 leads to extreme cell division abnormalities within cells. I will also study how cells initially respond to radiation induced DNA damage by exposing cells to radiation, following the application of the drug and determine how the immediate loss of BRCA1 impacts the different components of the cellular response to DNA damage. This research will uncover how cells react immediately following the loss of BRCA1 through aspects of cell division and response to DNA damage, and reveal previously uncharacterized early events in the disease progression of BRCA1 associated cancers.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gallant, Aidan K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~